Potential years of life lost due to neoplasms and oncology care coverage in Sergipe between 2020 and 2023
DOI:
https://doi.org/10.55892/jrg.v8i19.2596Keywords:
Years of life lost, Healthcare coverage, Neoplasms, Oncology, SergipeAbstract
Increased life expectancy and advances in diagnostic methods have contributed to the rise in the prevalence of chronic diseases, such as cancer, a rising cause of death in Brazil. This study analyzes the correlation between Years of Potential Life Lost (YPLL) due to neoplasms and cancer care coverage in the state of Sergipe, from 2020 to 2023. This is an observational, descriptive, and quantitative study based on secondary data from DATASUS. Indicators of incidence, mortality, and cancer care were evaluated, with YPLL calculated by age, sex, and municipality. Ethics approval was not required because the information is in the public domain. The results showed 56,855.5 PYLL due to cancer in Sergipe, corresponding to an average rate of 6.73 potential years of life lost per 1,000 inhabitants, between 2020 and 2023. The temporal analysis showed that 2023 presented the highest values, totaling approximately 15,653.5 PYLL, followed by 2020 (14,504 PYLL), 2022 (13,552.5 PYLL), and 2021 (13,145.5 PYLL). Regarding age groups, the 50-59 and 40-49 age groups contributed the most to the total potential years of life lost, while children and adolescents presented the lowest values. It was also observed that the Sergipe territory experienced an increase in PYLL in parallel with the concentration of the main cancer treatment centers in the capital, Aracaju. Thus, it is concluded that, even with the expansion of healthcare coverage, early mortality indicators remain high, reinforcing the need to decentralize oncology services and to use PYLL as a strategic tool for planning public policies that promote greater equity in care.
Downloads
References
BRASIL. Ministério da Saúde. Plano Nacional de Saúde 2020-2023. Brasília: Ministério da Saúde, 2020. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/plano_nacional_saude_2020_2023.pdf.
GALVÃO, Silvano Macedo et al. Potential years of life lost to cancer in Mato Grosso, stratified by sex: 2000 to 2019. Revista Brasileira de Epidemiologia, v. 25, supl. 1, p. e220009, 24 jun. 2022. DOI: 10.1590/1980-549720220009.supl.1.
GBD 2019 Adolescent Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncology, v. 23, n. 1, p. 27–52, jan. 2022. DOI: 10.1016/S1470-2045(21)00581-7.
GIOSEFFI, Janaína Rosenburg. Panorama da Radioterapia no Brasil entre 2018 e 2023. Observatório de Oncologia. Disponível em: https://observatoriodeoncologia.com.br/estudos/tratamento-em-oncologia/2024/panorama-da-radioterapia-no-brasil-entre-2018-e-2023. Acesso em: 18 set. 2025.
GUZMÁN-ESQUIVEL, Jose et al. Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019. International Urology and Nephrology, v. 55, n. 9, p. 2155–2160, set. 2023. DOI: 10.1007/s11255-023-03653-7.
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC). World Cancer Report: Cancer Research for Cancer Prevention. Lyon: IARC, 4 feb. 2020. Disponível em: https://www.iarc.who.int/featured-news/new-world-cancer-report/
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Sergipe – Cidades e Estado. Disponível em: https://www.ibge.gov.br/cidades-e-estados/se.html. Acesso em: 21 set. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Como surge o câncer. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/como-surge-o-cancer.
INSTITUTO NACIONAL DO CÂNCER. Sergipe – estimativas dos casos novos. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros/estimativa/estado-capital/sergipe . Acesso em: 20 set. 2025.
KOCARNIK, Jonathan M. et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncology, v. 8, n. 3, p. 420–444, mar. 2022. DOI: 10.1001/jamaoncol.2021.6987.
LI, Q.; LEI, X.; ZHU, J.; ZHONG, Y.; YANG, J.; WANG, J.; TAN, H. Radiotherapy/Chemotherapy‐Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications. Oxidative Medicine and Cellular Longevity, v. 2023, p. 7530794, 2023. DOI: 10.1155/2023/7530794.
MINISTÉRIO DA SAÚDE. Departamento de Informática do Sistema Único de Saúde – DATASUS. Produção Ambulatorial (SIA/SUS). Disponível em: https://datasus.saude.gov.br/acesso-a-informacao/producao-ambulatorial-sia-sus/. Acesso em: 28 out. 2025.
MINISTÉRIO DA SAÚDE. Departamento de Informática do Sistema Único de Saúde – DATASUS. Produção Hospitalar (SIH/SUS). Disponível em: https://datasus.saude.gov.br/acesso-a-informacao/producao-hospitalar-sih-sus/. Acesso em: 28 out. 2025
ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Câncer. Disponível em: https://www.who.int/health-topics/cancer#tab=tab_1. Acesso em: 22 set. 2025.
PRITCHARD-JONES, Kathy et al. The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. ecancermedicalscience, v. 15, p. 1187, 15 fev. 2021. DOI: 10.3332/ecancer.2021.1187.
RUMGAY, H, Cabasag CJ, Offman J, Cancela MdC, Barchuk A, Mathur P, Wang S, Wei W, Sasieni P, Soerjomataram I. International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States. EClinicalMedicine. 2023 Nov;66:102289. doi:10.1016/j.eclinm.2023.102289.
SOARES, Mariana Rosa et al. Mortality trend and analysis of potential years of life lost due to leukemia and lymphoma in Brazil and Mato Grosso. Revista Brasileira de Epidemiologia, v. 25, supl. 1, p. e220008, 24 jun. 2022. DOI: 10.1590/1980-549720220008.supl.1.
SBOC – SOCIEDADE BRASILEIRA DE ONCOLOGIA CLÍNICA. Censo da Oncologia Clínica é lançado no 1º dia do Congresso SBOC. São Paulo, 16 nov. 2023. Disponível em: https://sboc.org.br/noticias/item/3077-censo-da-oncologia-clinica-e-lancado-no-1-dia-do-congresso-sboc.
TIENGO, Tatiane; FERNANDES, Gisele Aparecida; CURADO, Maria Paula. Gastric adenocarcinoma: 1-year overall survival, disability-adjusted life years, years of life lost, and prognostic factors—a single-institution experience. Frontiers in Oncology, v. 12, p. 918833, 8 set. 2022. DOI: 10.3389/fonc.2022.918833.
YU, Pei et al. Loss of life expectancy from PM 2.5 in Brazil: A national study from 2010 to 2018. Environmental International, v. 166, p. 107350, ago. 2022. DOI: 10.1016/j.envint.2022.107350.
